Dr. Gifford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Pulmonary/Critical Care
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-844-2187
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2003 - 2007
- Pennsylvania State University College of MedicineClass of 2003
Certifications & Licensure
- OH State Medical License 2021 - 2025
- PA State Medical License 2022 - 2024
- NH State Medical License 2006 - 2022
- VT State Medical License 2003 - 2006
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis Start of enrollment: 2011 Jun 01
- Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung Start of enrollment: 2014 Apr 01
- Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsComparison of Dry Powder versus Nebulized Beta-Agonist in Patients with COPD Who Have Suboptimal Peak Inspiratory Flow RateDonald A. Mahler, Laurie A. Waterman, Joseph Ward, Alex H. Gifford
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2014-03-26 - 77 citationsPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.Donald A. Mahler, Laurie A. Waterman, Alex H. Gifford
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2013-05-24 - 243 citationsLongevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.Todd MacKenzie, Alex H. Gifford, Kathryn A. Sabadosa, Hebe B. Quinton, Emily A. Knapp
Annals of Internal Medicine. 2014-08-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: